Plasma-treated vascular occlusion devices and methods
View Patent ↗Vaso-occlusive devices are provided that have a polymer foam disposed about them. The polymer is treated with a plasma to facilitate thrombogenicity. A method for making and using such devices also is provided. The preferred polymer is a copolymer of a halogenated vinylidene and a halogenated alkene.
1. A coated vaso-occlusive product comprising:
a vaso-occlusive device that is an embolic coil;
a polymer disposed about said vaso-occlusive device, the polymer being poly(vinylidene fluoride-co-hexafluoropropylene), a copolymer of vinylidene fluoride and hexafluoropropylene, and the ratio of vinylidene fluoride to hexafluoropropylene in the copolymer is 85:15;
the polymer is in the form of an open cell foam having voids between polymer domains, the polymer foam having been exposed to helium plasma gas at between about 50 and 200 millitorr; and
said polymer foam has a surface flourine composition of less than about 40% and has a surface oxygen composition of at least about 10%, while said polymer foam has a water contact angle of said polymer that has been decreased due to its having been exposed to helium plasma gas, the decreased water contact angle of said polymer being from about 35 to about 85 degrees.
2. The product of claim 1 , wherein said vaso-occlusive device is made from a material selected from platinum, nitinol, radio-opaque materials, and combinations thereof.
3. The product of claim 1 wherein said decreased water contact angle of said polymer persists for at least 60 days.